Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
2.53B
-
Number of holders
-
3390
-
Total 13F shares, excl. options
-
1.94B
-
Shares change
-
-33.8M
-
Total reported value, excl. options
-
$174B
-
Value change
-
-$3.61B
-
Put/Call ratio
-
0.87
-
Number of buys
-
1460
-
Number of sells
-
-1842
-
Price
-
$89.76
Significant Holders of Merck & Co., Inc. - Common Stock (MRK) as of Q1 2025
3,776 filings reported holding MRK - Merck & Co., Inc. - Common Stock as of Q1 2025.
Merck & Co., Inc. - Common Stock (MRK) has 3,390 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.94B shares
of 2.53B outstanding shares and own 76.7% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (253M shares), BlackRock, Inc. (225M shares), STATE STREET CORP (121M shares), WELLINGTON MANAGEMENT GROUP LLP (81.7M shares), GEODE CAPITAL MANAGEMENT, LLC (59.7M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (49.2M shares), MORGAN STANLEY (43.1M shares), FMR LLC (31.8M shares), BANK OF AMERICA CORP /DE/ (31.1M shares), and NORTHERN TRUST CORP (30.4M shares).
This table shows the top 3390 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.